Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Bamco Inc. NY

Bamco Inc. NY decreased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 0.1% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 254,141 shares of the biotechnology company’s stock after selling 194 shares during the period. Bamco Inc. NY’s holdings in Axon Enterprise were worth $101,555,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. PFG Investments LLC lifted its position in Axon Enterprise by 0.6% in the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after acquiring an additional 25 shares during the last quarter. Gladstone Institutional Advisory LLC grew its holdings in shares of Axon Enterprise by 1.6% during the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock worth $656,000 after purchasing an additional 26 shares during the last quarter. Mather Group LLC. increased its position in shares of Axon Enterprise by 3.7% during the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock worth $303,000 after purchasing an additional 27 shares in the last quarter. King Luther Capital Management Corp lifted its holdings in shares of Axon Enterprise by 0.3% in the 3rd quarter. King Luther Capital Management Corp now owns 10,474 shares of the biotechnology company’s stock valued at $4,185,000 after purchasing an additional 34 shares during the last quarter. Finally, CWM LLC lifted its holdings in shares of Axon Enterprise by 1.3% in the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock valued at $1,141,000 after purchasing an additional 36 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on AXON. Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Barclays lifted their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. JMP Securities increased their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Needham & Company LLC raised their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, Robert W. Baird upped their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $427.83.

Axon Enterprise Trading Up 1.9 %

NASDAQ AXON opened at $646.96 on Monday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $49.33 billion, a P/E ratio of 167.17, a P/E/G ratio of 14.24 and a beta of 0.94. Axon Enterprise, Inc. has a 52-week low of $224.28 and a 52-week high of $652.22. The firm has a 50-day moving average price of $488.25 and a 200 day moving average price of $379.59.

Insider Transactions at Axon Enterprise

In other news, Director Julie A. Cullivan sold 900 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the transaction, the director now directly owns 3,653 shares of the company’s stock, valued at $1,291,445.09. This represents a 19.77 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 75,000 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $356.53, for a total transaction of $26,739,750.00. Following the completion of the sale, the chief executive officer now owns 2,970,366 shares of the company’s stock, valued at $1,059,024,589.98. This trade represents a 2.46 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 210,256 shares of company stock valued at $87,783,120. Corporate insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.